Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
about
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosisEntry inhibitors: New advances in HCV treatmentChronic hepatitis C virus infection and lipoprotein metabolismNovel functions of PXR in cardiometabolic disease.Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication.Genomic profiling of type-1 adult diabetic and aged normoglycemic mouse liver.Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.Dietary lipid content reorganizes gut microbiota and probiotic L. rhamnosus attenuates obesity and enhances catabolic hormonal milieu in zebrafish.Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient miceEzetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice.Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and rats.NPC1L1 knockout protects against colitis-associated tumorigenesis in mice.The chylomicron: relationship to atherosclerosis.Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver diseaseIntestinal pregnane X receptor links xenobiotic exposure and hypercholesterolemia.Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.Comparative digestive physiology.Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition.Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study.Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver.Ezetimibe-sensitive cholesterol uptake by NPC1L1 protein does not require endocytosis.The ins and outs of hepatitis C virus entry and assembly.Polymorphisms of the Niemann-Pick C1-like 1 gene in a Japanese population.Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.Pharmacogenetics of drug transporters in the enterohepatic circulation.Ezetimibe/simvastatin: a guide to its clinical use in hypercholesterolemia.Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.Nutraceuticals and functional foods in the management of hyperlipidemia.The perspective on cholesterol-lowering mechanisms of probiotics.Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.Phytosterols, Lipid Administration, and Liver Disease During Parenteral Nutrition.Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention.Semi-synthetic thymoquinone analogs: new prototypes as potential antihyperlipidemics in irradiated rats.Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia.Quantitation of the rates of hepatic and intestinal cholesterol synthesis in lysosomal acid lipase-deficient mice before and during treatment with ezetimibe.Di-(2-ethylhexyl) phthalate accelerates atherosclerosis in apolipoprotein E-deficient mice.PCSK9 inhibitors: A new era of lipid lowering therapy.
P2860
Q24629045-1E12A692-01D4-423C-AA8E-D8D2CF2CCE69Q26770817-432811F7-1E27-46F0-AC2C-CFDC11374DF4Q26784234-104F7CAE-C7AF-4669-96AF-A8B6B1B0B97AQ30251861-6A251A33-0ED2-4D0C-A5B9-99D7979AD6CDQ30552405-89E2EFD3-002F-4D76-885A-E45C2DDC4CECQ33592783-6A4F7A80-9E3D-4CC1-A9C8-1FEEAC29DC3DQ33759643-2A1AB548-4733-4AAE-82F4-74331E49A0D8Q33826605-0D8A53F8-AE84-46B8-BE3A-B921A5CD3D8CQ33911842-A3613AD1-EA75-45A0-839F-7CB2568F9FF1Q34356070-09DF77F7-090D-4133-BCE6-E445C73D6774Q34487963-3E40782D-2642-4AE8-9728-DB633741051EQ34980363-4AAA72B4-8E81-4E98-8BEC-4252BA28B225Q35173623-ACD59338-95A7-416C-AAC3-D54BF1408F17Q35228987-41A3EF0E-DFA1-4840-81BF-FD717B5FAA67Q35295065-F9DE1818-D54A-4B32-B5BE-017E42FB472CQ35550630-E7B3BB11-7B0E-4D9D-A555-C705CA0501A4Q35555694-F0C9D76C-93FF-46E5-AAE7-B172C0F3A64EQ35642818-AC52BFB7-EBA4-4CB7-A18C-A5E6193932E5Q35690188-2B4C9FAF-8C83-4EED-B5E0-BC85F0A04FCDQ35837416-136ED391-61C0-4C52-9ABD-D9338EDFA4F5Q36245202-05F451E4-BC42-4BF4-85C2-B1DA26DA13EDQ36824716-DA4142DF-E96B-4F1A-818B-CD3A50FB5FB0Q36944580-8C12D908-FEA7-4CB3-9070-0BBE9E772BB7Q37498626-F1035306-B983-4A5F-A0EB-ED814363281BQ37641652-9C9EFAC2-154B-44D3-9F55-B96835A99EE7Q37707904-CA3895AD-665A-4EF9-B1D2-A145C0BD1486Q37880875-CB643179-5916-4C55-9045-49C4B3973CC5Q37972314-6A0C04BF-7EFE-452E-BCAF-818123F3F3A7Q38166372-BD1C1F4D-F4DB-4A16-B6F0-8B9EB58511CEQ38185452-DDB8D10F-722A-464B-A4D7-D3C0EB3FC970Q38268792-7EB59F0A-D63B-4BB2-924B-F2476A7F5232Q38546242-E1AA0CBF-162A-48B5-8BA6-66B0E1E3701EQ38547689-0B18880A-E993-489E-ACB1-477C8E54F716Q38613429-C083210B-CC17-44B7-8888-808661ED718EQ38644523-0369FD3E-2DDA-4BA5-9AE3-90677111FE85Q38728564-FE8CB6A9-02E8-4C00-9197-6CB349B2A036Q38742876-52F02676-8EFE-4214-91A5-2EE7F471766DQ38891202-64C22934-695B-41B5-A413-62FB69156B24Q38951768-69D1B4A2-E369-4630-9325-4D1A5E787F32Q39176815-9AD83583-606A-43B4-87EC-F7B6D7E2779B
P2860
Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
@en
Niemann-pick C1-like 1
@nl
type
label
Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
@en
Niemann-pick C1-like 1
@nl
prefLabel
Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
@en
Niemann-pick C1-like 1
@nl
P2093
P2860
P1476
Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
@en
P2093
Jenna L Betters
P2860
P304
P356
10.1146/ANNUREV-PHYSIOL-012110-142233
P577
2011-01-01T00:00:00Z